ES2038597T3 - Metodo para detectar anticuerpos neutralizantes de virus en una muestra acuosa. - Google Patents

Metodo para detectar anticuerpos neutralizantes de virus en una muestra acuosa.

Info

Publication number
ES2038597T3
ES2038597T3 ES198686402610T ES86402610T ES2038597T3 ES 2038597 T3 ES2038597 T3 ES 2038597T3 ES 198686402610 T ES198686402610 T ES 198686402610T ES 86402610 T ES86402610 T ES 86402610T ES 2038597 T3 ES2038597 T3 ES 2038597T3
Authority
ES
Spain
Prior art keywords
virus
disturbance
water sample
neutralizing antibodies
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686402610T
Other languages
English (en)
Inventor
A. Gerard Quash
John Dennis Rodwell
Thomas Joseph Mckearn
Jean-Pierre Ripoll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Cytogen Corp
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Cytogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8517377A external-priority patent/FR2590674B1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Cytogen Corp filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of ES2038597T3 publication Critical patent/ES2038597T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

METODOS PARA DIAGNOSTICO, PROGNOSIS, PROFILAXIS Y TERAPIA DE LAS INFECCIONES VIRICAS DESCRITAS. LOS METODOS EMPLEAN UN VIRUS, ANTIGENO VIRICO O FRAGMENTOS DE ELLOS EN LOS CUALES LA "PERTURBACION" DE LA MITAD DESGARRADA DE UN OLIGOSACARIDO DEL VIRUS, ANTIGENO VIRICO, O FRAGMENTOS DE ELLOS MAS ESPECIFICAMENTE RECONOCIBLES O REACTIVOS CON ANTICUERPOS NEUTRALIZANTES. COMO ES DESCRITO LA "PERTURBACION" DE UNA MITAD DE OLIGOSACARIDO, ABARCA SIN MODIFICACION ALGUNA (1), ALTERAR LA ESTRUCTURA QUIMICA O FISICA DEL RESIDUO DE HIDRATO DE CARBONO QUE ESTA PRESENTE NATURALMENTE; (2) ELIMINAR TOTAL O PARCIALMENTE UN RESIDUO DE CARBOHIDRATO; Y (3) PREVENIR O ALTERAR LA ADICION DE RESIDUO DE CARBOHIDRATO. UNA VARIEDAD DE METODOS DE "PERTURBACION" DE OLIGOSACARIDOS SON TAMBIEN DESCRITOS.
ES198686402610T 1985-11-25 1986-11-25 Metodo para detectar anticuerpos neutralizantes de virus en una muestra acuosa. Expired - Lifetime ES2038597T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8517377A FR2590674B1 (fr) 1985-11-25 1985-11-25 Nouveaux reactifs de diagnostic
US06/928,631 US4853326A (en) 1985-11-25 1986-11-18 Carbohydrate perturbations of viruses or viral antigens and utilization for diagnostic prophylactic and/or therapeutic applications

Publications (1)

Publication Number Publication Date
ES2038597T3 true ES2038597T3 (es) 1993-08-01

Family

ID=26224838

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686402610T Expired - Lifetime ES2038597T3 (es) 1985-11-25 1986-11-25 Metodo para detectar anticuerpos neutralizantes de virus en una muestra acuosa.

Country Status (8)

Country Link
EP (1) EP0229546B1 (es)
AT (1) ATE67314T1 (es)
AU (1) AU592142B2 (es)
DE (1) DE3681428D1 (es)
ES (1) ES2038597T3 (es)
FI (1) FI873233A (es)
GR (1) GR3003323T3 (es)
WO (1) WO1987003206A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
EP0364492A1 (en) * 1987-06-30 1990-04-25 The Upjohn Company Virus proteins having reduced o-linked glycosylation
DE3884811T2 (de) * 1987-08-11 1994-02-24 Univ Minnesota Hyperimmun globulin gegen hiv.
US5164481A (en) * 1989-08-23 1992-11-17 Iaf Biochem International Inc. Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
US5427792A (en) * 1989-08-23 1995-06-27 Biochem Immunosystems, Inc. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
DE4025499A1 (de) * 1990-08-11 1992-02-13 Sandoz Ag Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen
EP2289547B1 (en) 2003-09-12 2015-12-16 Agenus Inc. Vaccine for treatment and prevention of herpes simplex virus infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378094A2 (fr) * 1977-01-24 1978-08-18 Inst Nat Sante Rech Med Nouveaux reactifs biologiques constitues par des supports solides sur lesquels sont couples des composes organiques comportant un residu glucidique
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
JPS54113492A (en) * 1978-02-24 1979-09-05 Sanyo Chem Ind Ltd Preparation of glucoprotein derivative
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
EP0117657A1 (en) * 1983-02-01 1984-09-05 Genentech, Inc. Rabies immunogenic polypeptides and vaccine using them, DNA sequences, expression vectors, recombinant cells, and cultures therefor, and processes for their production
FR2543570B1 (fr) * 1983-03-31 1985-08-09 Pasteur Institut Anticorps monoclonaux anticytomegalovirus humains, hybridomes secreteurs de ces anticorps et polypeptides porteurs d'un determinant antigenique sequentiel de cytomegalovirus humains
WO1984004327A1 (en) 1983-04-27 1984-11-08 Harvard College Method and products for detection of human t cell leukemia virus
US4634666A (en) * 1984-01-06 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Human-murine hybridoma fusion partner
US4743553A (en) * 1984-07-18 1988-05-10 W. R. Grace & Co. Synthetic genes for bovine parainfluenza virus

Also Published As

Publication number Publication date
GR3003323T3 (en) 1993-02-17
FI873233A0 (fi) 1987-07-23
EP0229546A1 (en) 1987-07-22
WO1987003206A1 (en) 1987-06-04
FI873233A (fi) 1987-07-23
ATE67314T1 (de) 1991-09-15
AU6723187A (en) 1987-07-01
DE3681428D1 (de) 1991-10-17
EP0229546B1 (en) 1991-09-11
AU592142B2 (en) 1990-01-04

Similar Documents

Publication Publication Date Title
ES8801319A1 (es) Un metodo para la deteccion de anticuerpos especificos de un virus lav en un fluido biologico.
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
NO873753D0 (no) Periodisk biologisk luftbehandlingsprosess og system for denne.
DK609985A (da) Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne
ES2100174T3 (es) Nuevos anticuerpos reactivos con carcinomas humanos.
ES2130121T3 (es) Antigeno intra-acrosomico de esperma humano para uso en una vacuna anticonceptiva.
SE8703225D0 (sv) Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections
ES2054667T3 (es) Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso.
ES2038597T3 (es) Metodo para detectar anticuerpos neutralizantes de virus en una muestra acuosa.
ES2062809T3 (es) Proteinas bacterianas del estres.
DE69223955D1 (de) Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren
ES2114064T3 (es) Inmunoanalisis para la deteccion de colageno o fragmentos de colageno.
ES547038A0 (es) Procedimiento de preparar sondas biologicas y oligonucleoticos.
PT82672B (pt) Processo para a preparacao de anticorpos monoclonais para carcinomas do pulmao de celulas nao-pequenas humanos
ES2066753T3 (es) Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas.
DE3381554D1 (de) Kombination zur absorbierung verschiedener kationen.
IT7819614A0 (it) Reattore per la depurazione biologica in continuo delle acque di rifiuto, particolarmente adattoper casette per fine settimana, villini per famiglie e simili.
ES2059539T3 (es) Metodo para la prevencion de la enfermedad del injerto frente al huesped.
ATE137674T1 (de) Von mca 16-88 erkanntes antigen
Boursnell et al. Studies with Marked Antisera 2. Variation in the Specific Adsorption by Red Cells from Different Rabbits of One 131I-marked rabbit ISO-Antiserum
ES2072331T3 (es) Procedimiento para la descontaminacion de cultivos celulares que contienen micoplasmas.
IT7821230A0 (it) Procedimento per scarniere pelli e dispositivo per l'esecuzione del procedimento.
MX2022011811A (es) Metodos y tratamiento con exceso de light libre.
SE8305667L (sv) Adenokarcinomrelaterade nya antigena determinanter och antikroppar som er specifika for dessa, forfarande for deras framstellning samt reagenssystem henforande sig till dem
Sayce et al. Human seminal orosomucoid and its possible use in medicolegal investigation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 229546

Country of ref document: ES